Diaz RM - Search Results

1

Vesicular stomatitis virus-induced immune suppressor cells generate antagonism between intratumoral oncolytic virus and cyclophosphamide.

Willmon C, Diaz RM, Wongthida P, Galivo F, Kottke T, Thompson J, Albelda S, Harrington K, Melcher A, Vile R. Willmon C, et al. Among authors: diaz rm. Mol Ther. 2011 Jan;19(1):140-9. doi: 10.1038/mt.2010.224. Epub 2010 Oct 26. Mol Ther. 2011. PMID: 20978474 Free PMC article.

2

Euro targeting in Leiden: the fourth meeting of the EWGT, University of Leiden, 14-17 November 1996.

Diaz RM, Vile R. Diaz RM, et al. Gene Ther. 1997 Jun;4(6):501-3. doi: 10.1038/sj.gt.3300445. Gene Ther. 1997. PMID: 9231064 No abstract available.

3

Exchange of viral promoter/enhancer elements with heterologous regulatory sequences generates targeted hybrid long terminal repeat vectors for gene therapy of melanoma.

Diaz RM, Eisen T, Hart IR, Vile RG. Diaz RM, et al. J Virol. 1998 Jan;72(1):789-95. doi: 10.1128/JVI.72.1.789-795.1998. J Virol. 1998. PMID: 9420288 Free PMC article.

4

Strategies for achieving multiple layers of selectivity in gene therapy.

Vile RG, Sunassee K, Diaz RM. Vile RG, et al. Among authors: diaz rm. Mol Med Today. 1998 Feb;4(2):84-92. doi: 10.1016/S1357-4310(97)01157-X. Mol Med Today. 1998. PMID: 9547795 Review.

5

Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancer.

Diaz RM, Todryk S, Chong H, Hart IR, Sikora K, Dorudi S, Vile RG. Diaz RM, et al. Gene Ther. 1998 Jul;5(7):869-79. doi: 10.1038/sj.gt.3300690. Gene Ther. 1998. PMID: 9813657

6

A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy.

Diaz RM, Bateman A, Emiliusen L, Fielding A, Trono D, Russell SJ, Vile RG. Diaz RM, et al. Gene Ther. 2000 Oct;7(19):1656-63. doi: 10.1038/sj.gt.3301277. Gene Ther. 2000. PMID: 11083474

7

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.

Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ. Galanis E, et al. Among authors: diaz rm. Hum Gene Ther. 2001 May 1;12(7):811-21. doi: 10.1089/104303401750148766. Hum Gene Ther. 2001. PMID: 11339897

8

A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.

Emiliusen L, Gough M, Bateman A, Ahmed A, Voellmy R, Chester J, Diaz RM, Harrington K, Vile R. Emiliusen L, et al. Among authors: diaz rm. Gene Ther. 2001 Jul;8(13):987-98. doi: 10.1038/sj.gt.3301470. Gene Ther. 2001. PMID: 11438833

9

The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles.

Kottke T, Qiao J, Diaz RM, Ahmed A, Vroman B, Thompson J, Sanchez-Perez L, Vile R. Kottke T, et al. Among authors: diaz rm. Gene Ther. 2006 Aug;13(15):1166-77. doi: 10.1038/sj.gt.3302722. Epub 2006 Apr 20. Gene Ther. 2006. PMID: 16625245

10

VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.

Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R. Qiao J, et al. Among authors: diaz rm. Gene Ther. 2006 Oct;13(20):1457-70. doi: 10.1038/sj.gt.3302782. Epub 2006 May 25. Gene Ther. 2006. PMID: 16724095

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters